Ligand Pharmaceuticals (LGND) Operating Income (2010 - 2026)
Ligand Pharmaceuticals (LGND) recorded Operating Income of $8.59 million in Q2 2026, up 1.7% from $8.44 million a year earlier but down 50.5% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Operating Income (2010 - 2026) Analysis & Trends
On a TTM basis, Ligand Pharmaceuticals' Operating Income came in at $94.73 million as of Jun 30, 2026; for FY2025, it came in at $41 million.
- Annual Operating Income has a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- Across earlier years, Operating Income came in at -$22.61 million in FY2024, $11.94 million in FY2023 (+293.2%), $3.04 million in FY2022 (-97.1%) and $103.85 million in FY2021 (+176.9%).
- Quarterly Operating Income has ranged from -$36.22 million in Q1 2025 to $54.93 million in Q3 2025 over the past five years.
- Peak year-over-year performance for Operating Income in the last five years was growth of 566.0% in Q1 2023, against a decline of 81.1% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.37 million (Q1 2026), $13.84 million (Q4 2025) and $54.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - | 8.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.59 Mn |
| Mar 31, 2026 | 17.37 Mn |
| Dec 31, 2025 | 13.84 Mn |
| Sep 30, 2025 | 54.93 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | -36.22 Mn |
| Dec 31, 2024 | -9.64 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | -19.10 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | -3.36 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | -1.98 Mn |
| Mar 31, 2023 | 14.21 Mn |
| Dec 31, 2022 | -20.10 Mn |
| Sep 30, 2022 | 12.34 Mn |
| Jun 30, 2022 | 8.66 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Dec 31, 2021 | 37.69 Mn |
| Sep 30, 2021 | 15.71 Mn |
API Access
Ligand Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();